Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
BackgroundT cell immunoreceptor with Ig and ITIM domains (TIGIT) interacts with poliovirus receptor (PVR) to contribute to cancer immune escape. Recently, TIGIT and PVR have been identified as promising immunotherapy targets. Their gene expression is upregulated in many solid tumors, but their prote...
Main Authors: | Florence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, Séverine Guiu, Angélique Bobrie, William Jacot |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1058424/full |
Similar Items
-
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
by: Hauke Stamm, et al.
Published: (2019-12-01) -
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
by: Xiuman Zhou, et al.
Published: (2020-09-01) -
PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2022-05-01) -
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
by: Alice L. Hung, et al.
Published: (2018-08-01) -
Studying TIGIT activity against tumors through the generation of knockout mice
by: Ahmed Rishiq, et al.
Published: (2023-12-01)